DBV Technologies (DBVT) Shares Issued (2018 - 2026)
DBV Technologies (DBVT) reported Shares Issued of $89.1 million for Q1 2026, down 43.88% on a QoQ basis from $158.8 million in Q4 2025.
DBV Technologies (DBVT) has 9 years of Shares Issued data on file, last reported at $89.1 million in Q1 2026.
- Quarterly Shares Issued changed N/A year-over-year to $89.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $364.8 million (up 55766.16% YoY) and the FY2025 annual result came in at $275.7 million, up 43386.75% from the prior year.
- Shares Issued declined to $89.1 million in Q1 2026 per DBVT's latest filing, from $158.8 million in the prior quarter.
- Across five years, Shares Issued topped out at $195.3 million in Q2 2022 and bottomed at -$864000.0 in Q3 2023.
- The 5-year median for Shares Issued is $326500.0 (2023), against an average of $55.9 million.
- The widest annual swing landed in 2022, when Shares Issued surged 25866.76%; it then sank 60.59% in 2023.
- Tracing DBVT's Shares Issued over 5 years: stood at -$261000.0 in 2022, then soared by 107.28% to $19000.0 in 2023, then surged by 3236.84% to $634000.0 in 2024, then jumped by 24942.59% to $158.8 million in 2025, then plunged by 43.88% to $89.1 million in 2026.
- Per Business Quant, the three latest DBVT Shares Issued figures stand at $89.1 million (Q1 2026), $158.8 million (Q4 2025), and $14000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | 89.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.10 Mn |
| Mar 31, 2026 | 89.10 Mn |
| Dec 31, 2025 | 158.77 Mn |
| Dec 31, 2025 | 158.77 Mn |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 116.92 Mn |
| Jun 30, 2025 | 116.92 Mn |
| Dec 31, 2024 | 634,000.00 |
| Dec 31, 2024 | 634,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Dec 31, 2023 | 19,000.00 |
| Sep 30, 2023 | -864,000.00 |
| Sep 30, 2023 | -864,000.00 |
| Dec 31, 2022 | -261,000.00 |
| Dec 31, 2022 | -261,000.00 |
| Sep 30, 2022 | -538,000.00 |
| Sep 30, 2022 | -538,000.00 |
| Jun 30, 2022 | 195.27 Mn |
| Jun 30, 2022 | 195.27 Mn |
| Jun 30, 2021 | 752,000.00 |
| Jun 30, 2021 | 752,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | -102,000.00 |
| Dec 31, 2020 | -102,000.00 |
| Sep 30, 2020 | -478,000.00 |
| Sep 30, 2020 | -478,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 151.02 Mn |
| Mar 31, 2020 | 151.02 Mn |
| Dec 31, 2019 | 60.81 Mn |
| Dec 31, 2019 | 60.81 Mn |
| Sep 30, 2019 | 73.87 Mn |
| Sep 30, 2019 | 73.87 Mn |
| Dec 31, 2018 | -151.25 Mn |
| Dec 31, 2018 | -151.25 Mn |
| Sep 30, 2018 | 154.88 Mn |
| Sep 30, 2018 | 154.88 Mn |